MK-801 protects against seizures induced by the cholinesterase inhibitor soman
- 1 July 1989
- journal article
- research article
- Published by Elsevier in Brain Research Bulletin
- Vol. 23 (1-2), 145-148
- https://doi.org/10.1016/0361-9230(89)90173-1
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizuresBrain Research, 1988
- Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock modelsNeuropharmacology, 1988
- The pharmacological selectivity of three NMDA antagonistsEuropean Journal of Pharmacology, 1988
- Systemic administration of MK-801 prevents neuronal degeneration in rat brainNeuroscience Letters, 1987
- Effects of Chronic Intake of Diazinon on Blood and Brain Monoamines and Amino AcidsDrug and Chemical Toxicology, 1986
- Possible Therapeutic Applications of Antagonists of Excitatory Amino acid NeurotransmittersClinical Science, 1985
- Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compoundActa Neuropathologica, 1983
- Restoration of shock‐suppressed behavior by treatment with (+)‐5‐methyl‐10,11‐dihydro‐5H‐dibenzo[a, d]cyclohepten‐5, 10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic propertiesDrug Development Research, 1982
- Presynaptic inhibitory action of acetylcholine in area CA1 of the hippocampusExperimental Neurology, 1978
- Presynaptic action of acetylcholine in thin sections from the guinea pig dentate gyrus in vitroExperimental Neurology, 1967